A Trial Comparing GSK1349572 50mg Once Daily to Raltegravir 400mg Twice Daily

PHASE3CompletedINTERVENTIONAL
Enrollment

828

Participants

Timeline

Start Date

October 19, 2010

Primary Completion Date

February 6, 2012

Study Completion Date

December 27, 2016

Conditions
Infection, Human Immunodeficiency Virus I
Interventions
DRUG

GSK1349572 (dolutegravir)

GSK1349572 50 mg taken once daily with or without food

DRUG

raltegravir

raltegravir 400mg taken twice daily

OTHER

GSK1349572 Placebo

GSK1349572 placebo taken once daily

OTHER

ABC/3TC

Abacavir/Lamivudine background therapy once daily

OTHER

TDF/FTC

Tenofovir/emtricitabine background therapy once daily

OTHER

raltegravir Placebo

raltegravir placebo taken twice daily

Trial Locations (101)

2010

GSK Investigational Site, Darlinghurst

GSK Investigational Site, Surry Hills

3004

GSK Investigational Site, Melbourne

10149

GSK Investigational Site, Turin

13003

GSK Investigational Site, Marseille

13353

GSK Investigational Site, Berlin

14004

GSK Investigational Site, Córdoba

15006

GSK Investigational Site, A Coruña

16128

GSK Investigational Site, Genoa

18014

GSK Investigational Site, Granada

20009

GSK Investigational Site, Washington D.C.

20014

GSK Investigational Site, San Sebastián

20146

GSK Investigational Site, Hamburg

20246

GSK Investigational Site, Hamburg

25123

GSK Investigational Site, Brescia

28006

GSK Investigational Site, Madrid

28029

GSK Investigational Site, Madrid

28034

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

28046

GSK Investigational Site, Madrid

28209

GSK Investigational Site, Charlotte

28805

GSK Investigational Site, Alcalá de Henares

28935

GSK Investigational Site, (Móstoles) Madrid

29010

GSK Investigational Site, Málaga

29203

GSK Investigational Site, Columbia

30202

GSK Investigational Site, Cartagena (Murcia)

30339

GSK Investigational Site, Atlanta

30625

GSK Investigational Site, Hanover

33316

GSK Investigational Site, Fort Lauderdale

34982

GSK Investigational Site, Ft. Pierce

36204

GSK Investigational Site, Vigo ( Pontevedra)

38320

GSK Investigational Site, La Laguna (Santa Cruz de Tenerife)

41071

GSK Investigational Site, Seville

44093

GSK Investigational Site, Nantes

44124

GSK Investigational Site, Cona (Ferrara)

44137

GSK Investigational Site, Dortmund

45100

GSK Investigational Site, Rovigo

46010

GSK Investigational Site, Valencia

50937

GSK Investigational Site, Cologne

53127

GSK Investigational Site, Bonn

60596

GSK Investigational Site, Frankfurt am Main

63108

GSK Investigational Site, St Louis

69437

GSK Investigational Site, Lyon

72207

GSK Investigational Site, Little Rock

75018

GSK Investigational Site, Paris

75181

GSK Investigational Site, Paris

75246

GSK Investigational Site, Dallas

75475

GSK Investigational Site, Paris

75571

GSK Investigational Site, Paris

75651

GSK Investigational Site, Paris

77004

GSK Investigational Site, Houston

77098

GSK Investigational Site, Houston

78705

GSK Investigational Site, Austin

80209

GSK Investigational Site, Denver

80335

GSK Investigational Site, Munich

85012

GSK Investigational Site, Phoenix

90048

GSK Investigational Site, Los Angeles

90069

GSK Investigational Site, Los Angeles

90502

GSK Investigational Site, Torrance

90762

GSK Investigational Site, Fürth

90813

GSK Investigational Site, Long Beach

92300

GSK Investigational Site, Levallois-Perret

92380

GSK Investigational Site, Garches

94275

GSK Investigational Site, Le Kremlin-Bicêtre

98104

GSK Investigational Site, Seattle

105275

GSK Investigational Site, Moscow

190103

GSK Investigational Site, Saint Petersburg

196645

GSK Investigational Site, Saint Petersburg

214006

GSK Investigational Site, Smolensk

302040

GSK Investigational Site, Oryol

350015

GSK Investigational Site, Krasnodar

398043

GSK Investigational Site, Lipetsk

400040

GSK Investigational Site, Volgograd

410009

GSK Investigational Site, Saratov

603005

GSK Investigational Site, N.Novgorod

614088

GSK Investigational Site, Perm

08844

GSK Investigational Site, Hillsborough

V6Z 1Y6

GSK Investigational Site, Vancouver

L8N 3Z5

GSK Investigational Site, Hamilton

K1H 8L6

GSK Investigational Site, Ottawa

M4N 3M5

GSK Investigational Site, Toronto

M4T 3A7

GSK Investigational Site, Toronto

H2L 5B1

GSK Investigational Site, Montreal

H2X 2P4

GSK Investigational Site, Montreal

00168

GSK Investigational Site, Rome

03010

GSK Investigational Site, Alicante

04009

GSK Investigational Site, Almería

08916

GSK Investigational Site, Badalona

08003

GSK Investigational Site, Barcelona

08025

GSK Investigational Site, Barcelona

08036

GSK Investigational Site, Barcelona

08907

GSK Investigational Site, Barcelona

Unknown

GSK Investigational Site, Granada

GSK Investigational Site, Murcia

08304

GSK Investigational Site, Mataró

B29 6JD

GSK Investigational Site, Birmingham

BN2 1ES

GSK Investigational Site, Brighton

M8 5RB

GSK Investigational Site, Crumpsall, Manchester

E1 1BB

GSK Investigational Site, London

SW10 9TH

GSK Investigational Site, London

Sponsors

Lead Sponsor

Collaborators (2)

All Listed Sponsors
collaborator

Shionogi

INDUSTRY

collaborator

GlaxoSmithKline

INDUSTRY

lead

ViiV Healthcare

INDUSTRY